|
|
||||||||
1 Department of Psychology, University of Washington, Seattle 98195-1525; 2 Department of Veterans Affairs, Puget Sound Health Care System, Seattle 98108; and 3 Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System and Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington 98195-1525
The mechanism(s)
underlying hypoglycemia-associated autonomic failure (HAAF) are
unknown. To test the hypothesis that the activation of brain regions
involved in the counterregulatory response to hypoglycemia is blunted
with HAAF, rats were studied in a 2-day protocol. Neuroendocrine
responses and brain activation (c-Fos immunoreactivity) were measured
during day 2 insulin-induced hypoglycemia (0.5 U
insulin · 100 g body
wt
1 · h
1 iv for 2 h) after
day 1 hypoglycemia (Hypo-Hypo) or vehicle. Hypo-Hypo animals
demonstrated HAAF with blunted epinephrine, glucagon, and
corticosterone (Cort) responses and decreased activation of the medial
hypothalamus [the paraventricular (PVN), dorsomedial (DMH), and
arcuate (Arc) nuclei]. To evaluate whether increases in day
1 Cort were responsible for the decreased hypothalamic activation,
Cort was infused intracerebroventricularly (72 µg) on
day 1 and the response to day 2 hypoglycemia was
measured. Intracerebroventricular Cort infusion failed to alter the
neuroendocrine response to day 2 hypoglycemia, despite
elevating both central nervous system and peripheral Cort levels.
However, day 1 Cort blunted responses in two of the same
hypothalamic regions as Hypo-Hypo (the DMH and Arc) but not in the PVN.
These results suggest that decreased activation of the PVN may be
important in the development of HAAF and that antecedent exposure to
elevated levels of Cort is not always sufficient to produce HAAF.
paraventricular nucleus; stress; c-Fos; hypoglycemia-associated autonomic failure
This article has been cited by other articles:
![]() |
N. M. Sanders, C. W. Wilkinson, G. J. Taborsky Jr., S. Al-Noori, W. Daumen, A. Zavosh, and D. P. Figlewicz The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E853 - E860. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Chan, H. Cheng, R. Herzog, D. Czyzyk, W. Zhu, A. Wang, R. J. McCrimmon, M. R. Seashore, and R. S. Sherwin Increased GABAergic Tone in the Ventromedial Hypothalamus Contributes to Suppression of Counterregulatory Reponses After Antecedent Hypoglycemia Diabetes, May 1, 2008; 57(5): 1363 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gustavson, D. A. Sandoval, A. C. Ertl, S. Bao, S. R. Raj, and S. N. Davis Stimulation of both type I and type II corticosteroid receptors blunts counterregulatory responses to subsequent hypoglycemia in healthy man Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E506 - E512. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. McCrimmon, M. Shaw, X. Fan, H. Cheng, Y. Ding, M. C. Vella, L. Zhou, E. C. McNay, and R. S. Sherwin Key Role for AMP-Activated Protein Kinase in the Ventromedial Hypothalamus in Regulating Counterregulatory Hormone Responses to Acute Hypoglycemia Diabetes, February 1, 2008; 57(2): 444 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cheng, L. Zhou, W. Zhu, A. Wang, C. Tang, O. Chan, R. S. Sherwin, and R. J. McCrimmon Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E705 - E712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Matveyenko, M. Bohland, M. Saberi, and C. M. Donovan Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E857 - E864. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Sanders, G. J. Taborsky Jr., C. W. Wilkinson, W. Daumen, and D. P. Figlewicz Antecedent Hindbrain Glucoprivation Does Not Impair the Counterregulatory Response to Hypoglycemia Diabetes, January 1, 2007; 56(1): 217 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jacobson, T. Ansari, J. Potts, and O. P. McGuinness Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E15 - E22. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jacobson, T. Ansari, and O. P. McGuinness Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E678 - E684. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Goldberg, R. Weiss, R. J. McCrimmon, E. V. Hintz, J. D. Dziura, and R. S. Sherwin Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure. Diabetes, April 1, 2006; 55(4): 1121 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Sandoval, L. Ping, R. A. Neill, B. Gong, K. Walsh, and S. N. Davis Brain region-dependent effects of dexamethasone on counterregulatory responses to hypoglycemia in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R413 - R419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Figlewicz, A. Zavosh, T. Sexton, and J. F. Neumaier Catabolic action of insulin in rat arcuate nucleus is not enhanced by exogenous "tub" expression Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E1004 - E1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. de Vries, M. A. Lawson, and J. Lee Beverly Dissociation of hypothalamic noradrenergic activity and sympathoadrenal responses to recurrent hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R910 - R915. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Evans, C. W. Wilkinson, P. Gronbeck, J. L. Bennett, A. Zavosh, G. J. Taborsky Jr, and D. P. Figlewicz Inactivation of the DMH selectively inhibits the ACTH and corticosterone responses to hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R123 - R128. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Sandoval, L. Ping, A. R. Neill, S. Morrey, and S. N. Davis Cortisol Acts Through Central Mechanisms to Blunt Counterregulatory Responses to Hypoglycemia in Conscious Rats Diabetes, September 1, 2003; 52(9): 2198 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Evans, C. W. Wilkinson, P. Gronbeck, J. L. Bennett, G. J. Taborsky Jr., and D. P. Figlewicz Inactivation of the PVN during hypoglycemia partially simulates hypoglycemia-associated autonomic failure Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R57 - R65. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |